Literature DB >> 9367300

Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria.

M T García-Silva1, A Ribes, Y Campos, B Garavaglia, J Arenas.   

Abstract

We report a boy 20 months of age with encephalopathy, petechiae, and ethylmalonic aciduria (EPEMA). Other clinical features were severe hypotonia, orthostatic acrocyanosis, and chronic diarrhea. Magnetic resonance imaging (MRI) of the brain demonstrated bilateral lesions in the lenticular and caudate nuclei, periaqueductal region, subcortical areas, white matter, and brainstem. Short and medium chain Acyl-CoA dehydrogenase and cytochrome c oxidase (COX) activities in fibroblasts were normal. Muscle histochemistry disclosed diffuse COX deficiency, and respiratory chain activities in muscle disclosed severe COX deficiency. Twelve other patients with similar clinical features have been reported. Muscle COX activity, studied only in four, demonstrated a clear-cut defect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367300     DOI: 10.1016/s0887-8994(97)00048-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  20 in total

1.  Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.

Authors:  Magalie Barth; Chris Ottolenghi; Laurence Hubert; Dominique Chrétien; Valérie Serre; Stéphanie Gobin; Stéphane Romano; Anne Vassault; Aziz Sefiani; Daniel Ricquier; Nathalie Boddaert; Michèle Brivet; Yves de Keyzer; Arnold Munnich; Marinus Duran; Daniel Rabier; Vassili Valayannopoulos; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

2.  Effect of in vivo administration of ethylmalonic acid on energy metabolism in rat tissues.

Authors:  Gustavo da C Ferreira; Karina Roth André; Patrícia Fernanda Schuck; Carolina M Viegas; Anelise Tonin; Daniella de Moura Coelho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2006-04-28       Impact factor: 3.584

3.  Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle.

Authors:  Alethea G Barschak; Gustavo da C Ferreira; Karina R André; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Carlos S Dutra Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2006-04-28       Impact factor: 3.584

Review 4.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

5.  Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

Authors:  Mustafa Kılıç; Özge Dedeoğlu; Rahşan Göçmen; Selman Kesici; Deniz Yüksel
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

6.  Ethylmalonic acid induces permeability transition in isolated brain mitochondria.

Authors:  Cristiane Cecatto; Alexandre Umpierrez Amaral; Guilhian Leipnitz; Roger Frigério Castilho; Moacir Wajner
Journal:  Neurotox Res       Date:  2014-02-21       Impact factor: 3.911

7.  Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes.

Authors:  X Fu; P Rinaldo; S H Hahn; H Kodama; S Packman
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid.

Authors:  Patrícia Fernanda Schuck; Estela Natacha Brandt Busanello; Alana Pimentel Moura; Anelise Miotti Tonin; Mateus Grings; Luciana Ritter; Carmen Regla Vargas; Gustavo da Costa Ferreira; Moacir Wajner
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

9.  Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.

Authors:  Valeria Tiranti; Carlo Viscomi; Tatjana Hildebrandt; Ivano Di Meo; Rossana Mineri; Cecilia Tiveron; Michael D Levitt; Alessandro Prelle; Gigliola Fagiolari; Marco Rimoldi; Massimo Zeviani
Journal:  Nat Med       Date:  2009-01-11       Impact factor: 53.440

10.  Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats.

Authors:  Patrícia F Schuck; Guilhian Leipnitz; César A J Ribeiro; Karina B Dalcin; Dênis R Assis; Alethea G Barschak; Vânia Pulrolnik; Clóvis M D Wannmacher; Angela T S Wyse; Moacir Wajner
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.